The Evaluation of HBsAg and Anti-HCV Seroprevalences of Blood Donors in Adiyaman

被引：0

作者：

Demiraslan, Hayati ^{[1
]}

Aksoz, Selcuk ^{[1
]}

机构：

[1] Adiyaman Deylet Hastanesi, Enfeksiyon Hastaliklan & Klin Mikrobiyol Klin, Adiyaman, Turkey

来源：

VIRAL HEPATIT DERGISI-VIRAL HEPATITIS JOURNAL | 2008年 / 13卷 / 01期

关键词：

Blood donors; HBsAg; anti-HCV; seroprevalance;

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

In our country it is an obligate to screen blood bank donors for transfusion-transmitted hepatitis B virus (HBV) and hepatitisCvirus (HCV). These screening tests are very important for the safety of transfusion and also give an idea about the prevalence of that region. In the present study, 12384 blood donors admitted to Blood Center of Adiyaman State Hospital from January 2002 to December 2008 were evaluated, retrospectively. The seropositivity rates for HBsAg and anti-HCV were found to be 3.3% and 0.3%, respectively. We believe that the results of the present study make a great contribution regarding identification of the frequency of HBsAg and anti-HCV positivity in our region.

引用

页码：23 / 26

页数：4

共 50 条

[41] Evaluation of Seroprevalence of HBsAg and Anti-HCV in the Patients Admitted to the Tunceli State Hospital
Asan, Ali
Akbulut, Ayhan
Sacar, Suzan
Turgut, Huseyin
[J]. VIRAL HEPATIT DERGISI-VIRAL HEPATITIS JOURNAL, 2011, 17 (02): : 52 - 56
[42] EVALUATION OF ANTI-HCV ELISA SEROPOSITIVITY IN VOLUNTARY BLOOD-DONORS - A PROPOSAL FOR DONOR COUNSELING STRATEGIES
BECKERS, EAM
THIJSSEN, PMHJ
NIJDAM, T
VANRHENEN, DJ
[J]. INFUSIONSTHERAPIE UND TRANSFUSIONSMEDIZIN, 1994, 21 (03): : 143 - 149
[43] DISTRIBUTION OF ABO AND RH BLOOD GROUPS AND SEROPREVALENCE OF HBSAG, ANTI-HCV, ANTI-HIV AND SYPHILIS IN HEALTHY DONORS: A SINGLE CENTER EXPERIENCE
Ekinci, O.
Kara, O.
Dogan, A.
Demircioglu, S.
Demir, C.
[J]. LEUKEMIA RESEARCH, 2017, 61 : S27 - S27
[44] Evaluation of HBsAg, Anti-HCV, Anti-HIV Seroprevalence and Perinatal Outcomes in Pregnant Women
Uckan, Kazim
Celegen, Izzet
Uckan, Taner
[J]. VIRAL HEPATIT DERGISI-VIRAL HEPATITIS JOURNAL, 2021, 27 (02): : 103 - 108
[45] POSITIVITY OF RHEUMATOID-FACTOR IN ANTI-HCV POSITIVE BLOOD-DONORS
SUAREZ, A
NAVASCUES, CA
DIEGUEZ, MA
RODRIGO, L
[J]. MEDICINA CLINICA, 1993, 101 (01): : 36 - 37
[46] THE PREVALENCE OF ANTI-HCV IN HEMODIALYSIS-PATIENTS AND BLOOD-DONORS IN GERMANY
HOLZBERGER, G
SEIDL, S
PESCHKE, B
FURSCH, A
SCHEUERMANN, EH
SCHOEPPE, W
[J]. TRANSPLANTATION PROCEEDINGS, 1991, 23 (05) : 2658 - 2659
[47] ANALYZING THE PERFORMANCE OF ANTI-HCV SUPPLEMENTAL TESTS IN GERMAN BLOOD-DONORS
CARDOSO, MD
KOERNER, K
EPPLE, S
KUBANEK, B
[J]. VOX SANGUINIS, 1995, 69 (01) : 73 - 74
[48] Anti-HCV envelope prevalence in blood donors from Baden-Wurttemberg
Cardoso, MD
Sturm, D
Koerner, K
Dengler, T
Kerowgan, M
Kubanek, B
[J]. ANNALS OF HEMATOLOGY, 1997, 74 (03) : 135 - 137
[49] EPIDEMIOLOGIC-STUDY OF ANTI-HCV ANTIBODY IN TUNISIAN BLOOD-DONORS
SLAMA, H
MOJAAT, N
DAHRI, R
BOUKEF, K
[J]. REVUE FRANCAISE DE TRANSFUSION ET D HEMOBIOLOGIE, 1991, 34 (06): : 459 - 464
[50] Comparison of anti-HCV using EIA and PRISM in blood versus cord donors
Rhamy, J.
Terry, T.
White, L.
Waxman, D.
[J]. TRANSFUSION, 2008, 48 (02) : 94A - 95A

← 1 2 3 4 5 →